Literature DB >> 30276937

Primary effusion lymphoma of the pleural space: Report of a rare complication of cardiac transplant with review of the literature.

Irfan Ali R Kugasia1, Arun Kumar2, Akshay Khatri2, Faisal Saeed3, Humayun Islam3, Oleg Epelbaum1.   

Abstract

Primary effusion lymphoma (PEL) is a rare mature B-cell non-Hodgkin's lymphoma arising in body cavities and presenting with effusions. It has been described predominantly in patients with impaired immunity from the acquired immunodeficiency syndrome and is associated with the Human Herpesvirus-8 (HHV-8). Seldom has PEL been diagnosed in persons negative for the human immunodeficiency virus (HIV), and in such cases it has occurred primarily in the setting of posttransplant immunosuppression. We report an instructive case of a Caribbean-American HIV-negative orthotopic heart transplant recipient with a history of HHV-8-associated Kaposi's sarcoma who developed HHV-8 viremia and PEL of the pleural space early in the posttransplant course. This case highlights the importance of considering PEL in the differential diagnosis of a new pleural effusion in a transplant recipient at risk for HHV-8-associated disease.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  heart transplant; human herpesvirus-8; pleural effusion; primary effusion lymphoma

Mesh:

Year:  2018        PMID: 30276937     DOI: 10.1111/tid.13005

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  2 in total

1.  Primary effusion lymphoma (PEL) in a renal transplant patient.

Authors:  Raghda Noureldin; Syed Athar; Vidya Nagrale; Waqar Gaba
Journal:  Clin Med (Lond)       Date:  2020-03       Impact factor: 2.659

2.  Primary effusion lymphoma occurring in the setting of transplanted patients: a systematic review of a rare, life-threatening post-transplantation occurrence.

Authors:  Magda Zanelli; Francesca Sanguedolce; Maurizio Zizzo; Andrea Palicelli; Maria Chiara Bassi; Giacomo Santandrea; Giovanni Martino; Alessandra Soriano; Cecilia Caprera; Matteo Corsi; Stefano Ricci; Linda Ricci; Stefano Ascani
Journal:  BMC Cancer       Date:  2021-04-27       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.